IP Library Granted Patent US 12,674,851
Granted Patent B2
US 12,674,851 · App. 18/084,983 · Granted Jul 7, 2026

Biomagnetic field sensor systems and methods for diagnostic evaluation of cardiac conditions

Inventors: Emmanuel T. Setegn (Mason, OH); Peeyush Shrivastava (Mason, OH); Rhea Malhotra (Mason, OH); Vineet Naveen Erasala (Mason, OH); Raj Muchhala (Mason, OH); Benjamin Donaldson Moore (Mason, OH)
Assignee: SB Technology, Inc.
G01R33/0094A61B5/05A61B5/242A61B5/243A61B5/4842A61B5/6835A61B5/7264G01R33/022G01R33/4215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,851
App. No.
18/084,983
Granted
Jul 7, 2026
Kind
B2
Abstract

The present disclosure provides a biomagnetic field sensor system for diagnostic evaluation of a cardiac condition of an individual. The biomagnetic field sensor system may comprise an array of biomagnetic field sensors configured to sense an electromagnetic field associated with a heart of the individual and generate electromagnetic field data therefrom; a computer processor coupled to the array of biomagnetic field sensors; a memory configured to store the electromagnetic field data generated by the array of biomagnetic field sensors; and a non-transitory computer-readable medium encoded with a computer program including instructions that, when executed by the computer processor, cause the computer processor to receive the electromagnetic field data, and generate a diagnostic evaluation of a cardiac condition of the individual based at least in part on an analysis of the electromagnetic field data.

Claims (43)

1 . A biomagnetic field sensor system for diagnostic evaluation of an individual, comprising:

an array of biomagnetic field sensors configured to acquire electromagnetic field (EMF) signals associated with a tissue, an organ, or a body part of the individual and generate magnetic field measurements therefrom;

a computer processor coupled to the array of biomagnetic field sensors; and

a memory coupled to the computer processor, the memory storing instructions that are configured to be executed by the computer processor, the instructions, when executed by the computer processor, cause the biomagnetic field sensor system to:

receive the EMF signals acquired by the array of biomagnetic field sensors;

filter the EMF signals to obtain filtered data;

execute a machine learning algorithm to process the filtered data, wherein the machine learning algorithm is trained to construct a hypothesis function according to training data comprising EMF measurements and corresponding abnormality data, to determine presence of one or more abnormalities in human subjects, the machine learning algorithm including a plurality of blocks of dilated convolutional neural networks, a respective block comprising a respective number of layers and a respective set of dilation rates, and wherein executing the machine learning algorithm includes:

constructing, by the machine learning model, the hypothesis function based on the filtered data;

determining, by the machine learning algorithm, whether an outcome of the hypothesis function is achieved; and

determining, by the machine learning algorithm based on the outcome of the hypothesis function, whether an abnormality is present in the individual; and

receive, as output via the machine learning algorithm, an analysis result indicating a presence or an absence of an abnormality of the tissue, the organ, or the body part of the individual, wherein the presence of the abnormality includes localization of the abnormality to a particular region of the tissue, organ, or body part.

2 . The biomagnetic field sensor system of claim 1 , further comprising a shield configured to shield at least a portion of a body of the individual from an environmental magnetic field.

3 . The biomagnetic field sensor system of claim 2 , wherein the shield is configured to at least partially enclose the at least the portion of the body of the individual, including at least a portion of a chest of the individual.

4 . The biomagnetic field sensor system of claim 2 , wherein the shield comprises a permalloy or a mumetal.

5 . The biomagnetic field sensor system of claim 1 , further comprising a movable base unit, and an arm having a proximal end and a distal end, the proximal end being coupled to the movable base unit by a first joint, the first joint configured so that the arm moves relative to the movable base unit with at least one degree of freedom.

6 . The biomagnetic field sensor system of claim 5 , wherein the arm comprises a proximal segment and a distal segment, and wherein a second joint is positioned between the proximal segment and the distal segment and is configured so that the distal segment articulates relative to the proximal segment.

7 . The biomagnetic field sensor system of claim 5 , wherein the array of biomagnetic field sensors is movably coupled to the distal end of the arm so that the array moves relative to the arm with at least one degree of freedom.

8 . The biomagnetic field sensor system of claim 1 , wherein the array of biomagnetic field sensors is arranged to match a generalized contour of a portion of a body of the individual.

9 . The biomagnetic field sensor system of claim 1 , wherein the instructions, when executed by the computer processor, cause the computer processor to further generate a visual representation of the magnetic field measurements comprising a waveform.

10 . The biomagnetic field sensor system of claim 9 , wherein the visual representation comprises a magnetocardiogram (MCG).

11 . The biomagnetic field sensor system of claim 9 , wherein the visual representation comprises an electric current map.

12 . The biomagnetic field sensor system of claim 1 , wherein the analysis result is indicative of a location of the abnormality, a type of the abnormality, or present conditions associated with the abnormality.

13 . The biomagnetic field sensor system of claim 1 , wherein the instructions, when executed by the computer processor, cause the computer processor to further localize an anatomical region of the body, organ, or tissue associated with the abnormality.

14 . The biomagnetic field sensor system of claim 1 , wherein the diagnostic evaluation comprises a diagnosis of the individual.

15 . The biomagnetic field sensor system of claim 1 , wherein the diagnostic evaluation comprises a prognosis of the individual.

16 . The biomagnetic field sensor system of claim 1 , wherein the array of biomagnetic field sensors comprises optically pumped magnetometer (OPM) sensors, magnetic induction sensors, magneto-resistive sensors, superconducting quantum interference device (SQUID) sensors, or a combination thereof.

17 . The biomagnetic field sensor system of claim 1 , wherein the array of biomagnetic field sensors is configured to be positioned outside of a body of the individual and not in contact with the body of the individual, in order to non-invasively acquire the EMF signals.

18 . The biomagnetic field sensor system of claim 1 , wherein the tissue, the organ, or the body part of the individual is a heart of the individual.

19 . The biomagnetic field sensor system of claim 18 , wherein the abnormality comprises ischemia or coronary artery disease (CAD).

20 . The biomagnetic field sensor system of claim 1 , wherein the tissue, the organ, or the body part of the individual is a brain of the individual.

21 . The biomagnetic field sensor system of claim 20 , wherein the abnormality is associated with stroke, traumatic brain injury, traumatic spine injury, encephalitis, meningitis, brain tumor, Alzheimer's disease, Parkinson's disease, ataxia, or a psychiatric disorder.

22 . The biomagnetic field sensor system of claim 1 , wherein the tissue, the organ, or the body part of the individual is a liver or a pancreas of the individual.

23 . The biomagnetic field sensor system of claim 1 , wherein the tissue, the organ, or the body part of the individual is a gastrointestinal tract of the individual.

24 . The biomagnetic field sensor system of claim 23 , wherein the abnormality is associated with a gastrointestinal cancer, Crolm's disease, ulcerative colitis, irritable bowel disease, dismotility disorder, gall stone, colitis, cholangitis, liver failure, pancreatitis, or a gastrointestinal infection.

25 . The biomagnetic field sensor system of claim 1 , further comprising executing, by the machine learning algorithm, automatic statistical analysis of the filtered data to determine which one or more features to extract and analyze.

26 . The biomagnetic field sensor system of claim 1 , wherein the machine learning algorithm is trained by repeatedly presenting the machine learning algorithm with EMF data together with abnormality data concerning an existence or non-existence of an abnormality in an organ, tissue, body, or portion thereof, the abnormality data further including information concerning an absence of an irregular health condition in a subject.

27 . The biomagnetic field sensor system of claim 1 , wherein the machine learning algorithm is trained on a single EMF measurement with accompanying abnormality data, the single EMF measurement having multiple, continuous segments of EMF signals.

28 . The biomagnetic field sensor system of claim 1 , wherein the instructions, when executed by the computer processor, cause the biomagnetic field sensor system to:

after receiving the EMF signals acquired by the array of biomagnetic field sensors, encode the received EMF signals to audio signals; and

filter the audio signals to obtain the filtered data.

29 . The biomagnetic field sensor system of claim 1 , wherein filtering the EMF signals to obtain filtered data includes:

converting the received EMF signals into one or more signals having a morphology of an audio signal wave; and

generating one or more coefficients for a short term power spectrum of a sound.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: GENETESIS, INC.
To: SB TECHNOLOGY, INC.
Reel/Frame 072753/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2025
From: GENETESIS, INC.
To: SB TECHNOLOGY, INC.
Reel/Frame 072536/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2023
From: MUCHHALA, RAJ
To: GENETESIS, INC.
Reel/Frame 064616/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2023
From: SETEGN, EMMANUEL T.; SHRIVASTAVA, PEEYUSH; MALHOTRA, RHEA; ERASALA, VINEET NAVEEN; MOORE, BENJAMIN DONALDSON
To: GENETESIS, INC.
Reel/Frame 064408/0097 →
Continuity (3)
Continuation 17181095 · Feb 22, 2021
Continuation In Part 16271705 · Feb 8, 2019
Related Publication 20230204688A1 · Jun 29, 2023
References Cited (347)
US 4600886A · Jensen · 1986 [cited by applicant]
US 5122744A · Koch · 1992 [cited by applicant]
US 5697369A · Long, Jr. et al. · 1997 [cited by applicant]
US 5715821A · Faupel · 1998 [cited by applicant]
US 5771894A · Richards et al. · 1998 [cited by applicant]
US 5785653A · Kiyuna et al. · 1998 [cited by applicant]
US 6195576B1 · John · 2001 [cited by applicant]
US 6230037B1 · Tsukada et al. · 2001 [cited by applicant]
US 6339328B1 · Keene et al. · 2002 [cited by applicant]
US 6385479B1 · Sibbitt et al. · 2002 [cited by applicant]
US 6390098B1 · LaFontaine et al. · 2002 [cited by applicant]
US 6522908B1 · Miyashita et al. · 2003 [cited by applicant]
US 6597940B2 · Bishop et al. · 2003 [cited by applicant]
US 7270670B1 · Yencho · 2007 [cited by applicant]
US 7395107B2 · Ishiyama et al. · 2008 [cited by applicant]
US 7599728B2 · Feenan · 2009 [cited by applicant]
US 7634360B2 · Davalos et al. · 2009 [cited by applicant]
US 7646274B2 · Rapoport · 2010 [cited by applicant]
US 7801591B1 · Shusterman · 2010 [cited by applicant]
US 7805179B2 · Horng et al. · 2010 [cited by applicant]
US 8060179B1 · Flynn · 2011 [cited by applicant]
US 8172776B2 · Browne · 2012 [cited by applicant]
US 8310230B2 · Haensch et al. · 2012 [cited by applicant]
US 8315713B2 · Burnes et al. · 2012 [cited by applicant]
US 8323188B2 · Tran · 2012 [cited by applicant]
US 8553956B2 · Wu et al. · 2013 [cited by applicant]
US 9433363B1 · Erasala et al. · 2016 [cited by applicant]
US 9788741B2 · Erasala et al. · 2017 [cited by applicant]
US 10076256B2 · Erasala et al. · 2018 [cited by applicant]
US 10140421B1 · Bernard et al. · 2018 [cited by applicant]
US 10602940B1 · Muchhala · 2020 [cited by examiner]
US 10925502B2 · Muchhala · 2021 [cited by examiner]
US 10952628B2 · Erasala et al. · 2021 [cited by applicant]
US 11134877B2 · Erasala et al. · 2021 [cited by applicant]
US 11375935B2 · Muchhala · 2022 [cited by examiner]
US 11517235B2 · Muchhala et al. · 2022 [cited by applicant]
US 11585869B2 · Setegn · 2023 [cited by examiner]
US 11903714B2 · Muchhala · 2024 [cited by examiner]
US 12097032B2 · Muchhala et al. · 2024 [cited by applicant]
US 20010029329A1 · Avrin et al. · 2001 [cited by applicant]
US 20020045813A1 · Suzuki et al. · 2002 [cited by applicant]
US 20020077537A1 · Avrin et al. · 2002 [cited by applicant]
US 20020103428A1 · deCharms · 2002 [cited by applicant]
US 20030018277A1 · He · 2003 [cited by applicant]
US 20030097056A1 · Suzuki et al. · 2003 [cited by applicant]
US 20030135128A1 · Suffin et al. · 2003 [cited by applicant]
US 20030149354A1 · Bakharev · 2003 [cited by applicant]
US 20030218872A1 · Tsukada · 2003 [cited by examiner]
US 20040039291A1 · Nakai et al. · 2004 [cited by applicant]
US 20040106863A1 · Seki et al. · 2004 [cited by applicant]
US 20040232912A1 · Tsukamoto · 2004 [cited by examiner]
US 20040243022A1 · Carney et al. · 2004 [cited by applicant]
US 20040254443A1 · Gott et al. · 2004 [cited by applicant]
US 20050020903A1 · Krishnan et al. · 2005 [cited by applicant]
US 20050096531A1 · Oonuma et al. · 2005 [cited by applicant]
US 20050148844A1 · Ogata et al. · 2005 [cited by applicant]
US 20050152703A1 · Ogawa · 2005 [cited by applicant]
US 20050192502A1 · Ishiyama et al. · 2005 [cited by applicant]
US 20050285492A1 · Hu et al. · 2005 [cited by applicant]
US 20060055402A1 · Seki · 2006 [cited by examiner]
US 20060122525A1 · Shusterman · 2006 [cited by applicant]
US 20060149354A1 · Shanley et al. · 2006 [cited by applicant]
US 20060234304A1 · Amann-Zalan et al. · 2006 [cited by applicant]
US 20060277075A1 · Salwan · 2006 [cited by applicant]
US 20070120563A1 · Kawabata et al. · 2007 [cited by applicant]
US 20070167723A1 · Park et al. · 2007 [cited by applicant]
US 20070167846A1 · Sternickel et al. · 2007 [cited by applicant]
US 20070213600A1 · John et al. · 2007 [cited by applicant]
US 20070276270A1 · Tran · 2007 [cited by applicant]
US 20080033312A1 · Nakai et al. · 2008 [cited by applicant]
US 20080091118A1 · Georgopoulos · 2008 [cited by applicant]
US 20080108504A1 · Matsui et al. · 2008 [cited by applicant]
US 20080137927A1 · Altmann et al. · 2008 [cited by applicant]
US 20080306359A1 · Zdeblick et al. · 2008 [cited by applicant]
US 20090149736A1 · Skidmore et al. · 2009 [cited by applicant]
US 20090172773A1 · Moore · 2009 [cited by applicant]
US 20090177107A1 · Guion-Johnson · 2009 [cited by applicant]
US 20090281413A1 · Boyden et al. · 2009 [cited by applicant]
US 20090295385A1 · Brazdeikis et al. · 2009 [cited by applicant]
US 20090295386A1 · Sato et al. · 2009 [cited by applicant]
US 20090299200A1 · Eggenberger et al. · 2009 [cited by applicant]
US 20100004708A1 · Jahns et al. · 2010 [cited by applicant]
US 20100036269A1 · Ferren et al. · 2010 [cited by applicant]
US 20100090697A1 · Savukov et al. · 2010 [cited by applicant]
US 20100249620A1 · Cho · 2010 [cited by applicant]
US 20110041520A1 · Erne et al. · 2011 [cited by applicant]
US 20110047105A1 · Sternickel et al. · 2011 [cited by applicant]
US 20110119212A1 · De Bruin et al. · 2011 [cited by applicant]
US 20110152703A1 · Zuckerman et al. · 2011 [cited by applicant]
US 20110160546A1 · Madsen · 2011 [cited by applicant]
US 20110224962A1 · Goldberger et al. · 2011 [cited by applicant]
US 20110275949A1 · Harlev et al. · 2011 [cited by applicant]
US 20110306896A1 · Altmann · 2011 [cited by applicant]
US 20110313274A1 · Subbarao · 2011 [cited by applicant]
US 20120197145A1 · Wu et al. · 2012 [cited by applicant]
US 20120219195A1 · Wu et al. · 2012 [cited by applicant]
US 20120239560A1 · Pourfallah et al. · 2012 [cited by applicant]
US 20120284332A1 · Pradeep et al. · 2012 [cited by applicant]
US 20120289954A1 · Lam · 2012 [cited by applicant]
US 20120310107A1 · Doidge et al. · 2012 [cited by applicant]
US 20130038325A1 · Okada · 2013 [cited by applicant]
US 20130057385A1 · Murakami et al. · 2013 [cited by applicant]
US 20130072780A1 · Espy et al. · 2013 [cited by applicant]
US 20130079622A1 · Wu et al. · 2013 [cited by applicant]
US 20130096394A1 · Gupta et al. · 2013 [cited by applicant]
US 20130132109A1 · Mruthyunjaya et al. · 2013 [cited by applicant]
US 20130184569A1 · Strommer et al. · 2013 [cited by applicant]
US 20130203061A1 · Kuslich et al. · 2013 [cited by applicant]
US 20130241929A1 · Massarwa et al. · 2013 [cited by applicant]
US 20130317337A1 · Wu et al. · 2013 [cited by applicant]
US 20130324832A1 · Wu et al. · 2013 [cited by applicant]
US 20140107511A1 · Banet et al. · 2014 [cited by applicant]
US 20140171757A1 · Kawato et al. · 2014 [cited by applicant]
US 20140308930A1 · Tran · 2014 [cited by applicant]
US 20140323848A1 · He et al. · 2014 [cited by applicant]
US 20140343396A1 · Sternickel et al. · 2014 [cited by applicant]
US 20140343397A1 · Kim et al. · 2014 [cited by applicant]
US 20140379269A1 · Schmitt · 2014 [cited by applicant]
US 20150011844A1 · Paradis · 2015 [cited by applicant]
US 20150011862A1 · Chaykovskyy · 2015 [cited by applicant]
US 20150080703A1 · Reiman · 2015 [cited by applicant]
US 20150150475A1 · Varcoe · 2015 [cited by applicant]
US 20150212166A1 · Kandori et al. · 2015 [cited by applicant]
US 20150366546A1 · Kamen et al. · 2015 [cited by applicant]
US 20160007879A1 · Gonzalez et al. · 2016 [cited by applicant]
US 20160044841A1 · Chamberlain · 2016 [cited by applicant]
US 20160066860A1 · Sternickel et al. · 2016 [cited by applicant]
US 20160120432A1 · Sridhar et al. · 2016 [cited by applicant]
US 20160131723A1 · Nagasaka · 2016 [cited by applicant]
US 20160135706A1 · Sullivan et al. · 2016 [cited by applicant]
US 20160154072A1 · Nagasaka et al. · 2016 [cited by applicant]
US 20160154073A1 · Nagasaka et al. · 2016 [cited by applicant]
US 20160287166A1 · Tran · 2016 [cited by applicant]
US 20170007148A1 · Kaditz et al. · 2017 [cited by applicant]
US 20170027498A1 · Larson et al. · 2017 [cited by applicant]
US 20170032922A1 · Champeaux et al. · 2017 [cited by applicant]
US 20170053082A1 · Pereira et al. · 2017 [cited by applicant]
US 20170071499A1 · Nebuya et al. · 2017 [cited by applicant]
US 20170135633A1 · Connor · 2017 [cited by applicant]
US 20170173262A1 · Veltz · 2017 [cited by applicant]
US 20170202509A1 · Sanderson et al. · 2017 [cited by applicant]
US 20170258348A1 · Erasala et al. · 2017 [cited by applicant]
US 20170329922A1 · Eberting et al. · 2017 [cited by applicant]
US 20170332918A1 · Keane · 2017 [cited by applicant]
US 20170352158A1 · Raina · 2017 [cited by applicant]
US 20180000371A1 · Gupta et al. · 2018 [cited by applicant]
US 20180064400A1 · Chbat et al. · 2018 [cited by applicant]
US 20180070841A1 · Honore et al. · 2018 [cited by applicant]
US 20180078146A1 · Shadforth et al. · 2018 [cited by applicant]
US 20180078767A1 · Rapoport et al. · 2018 [cited by applicant]
US 20180089531A1 · Geva et al. · 2018 [cited by applicant]
US 20180093092A1 · Howard · 2018 [cited by applicant]
US 20180128886A1 · Nagasaka · 2018 [cited by applicant]
US 20180158552A1 · Liu et al. · 2018 [cited by applicant]
US 20180224508A1 · Kelly et al. · 2018 [cited by applicant]
US 20180235470A1 · Johnson et al. · 2018 [cited by applicant]
US 20180236255A1 · Etkin · 2018 [cited by applicant]
US 20180263561A1 · Jones · 2018 [cited by applicant]
US 20180322351A1 · Shaker · 2018 [cited by applicant]
US 20180333063A1 · Muchhala et al. · 2018 [cited by applicant]
US 20180333104A1 · Sitek · 2018 [cited by applicant]
US 20190018080A1 · Marauska et al. · 2019 [cited by applicant]
US 20190021621A1 · Erasala et al. · 2019 [cited by applicant]
US 20190046059A1 · Erasala et al. · 2019 [cited by applicant]
US 20190108833A1 · van den Oord et al. · 2019 [cited by applicant]
US 20190117164A1 · Gupta et al. · 2019 [cited by applicant]
US 20190167136A1 · Kawabata et al. · 2019 [cited by applicant]
US 20190192021A1 · Kim et al. · 2019 [cited by applicant]
US 20190336231A1 · Kidd et al. · 2019 [cited by applicant]
US 20190365266A1 · Varcoe et al. · 2019 [cited by applicant]
US 20190368191A1 · Shibuya · 2019 [cited by applicant]
US 20200081079A1 · Khitun · 2020 [cited by applicant]
US 20200152330A1 · Anushiravani et al. · 2020 [cited by applicant]
US 20200170528A1 · Erasala et al. · 2020 [cited by applicant]
US 20200187802A1 · Muchhala et al. · 2020 [cited by applicant]
US 20200211713A1 · Shadforth et al. · 2020 [cited by applicant]
US 20200258627A1 · Setegn et al. · 2020 [cited by applicant]
US 20200388287A1 · Anushiravani et al. · 2020 [cited by applicant]
US 20210027893A1 · Nematihosseinabadi et al. · 2021 [cited by applicant]
US 20210161420A1 · Nakamura · 2021 [cited by examiner]
US 20210325482A1 · Setegn et al. · 2021 [cited by applicant]
US 20220015677A1 · Erasala et al. · 2022 [cited by applicant]
US 20230181077A1 · Muchhala et al. · 2023 [cited by applicant]
US 20240245335A1 · Erasala et al. · 2024 [cited by applicant]
US 20250000417A1 · Erasala et al. · 2025 [cited by applicant]
CN 1259025A · 2000 [cited by applicant]
CN 1471374A · 2004 [cited by applicant]
CN 101926646A · 2010 [cited by applicant]
CN 102355859A · 2012 [cited by applicant]
CN 104188650A · 2014 [cited by applicant]
CN 204133457U · 2015 [cited by applicant]
CN 104620123A · 2015 [cited by applicant]
CN 108245152A · 2018 [cited by examiner]
CN 108577825A · 2018 [cited by examiner]
CN 113316412A · 2021 [cited by applicant]
EP 1302160A1 · 2003 [cited by applicant]
EP 3077037A1 · 2016 [cited by applicant]
EP 3308703A1 · 2018 [cited by applicant]
EP 3883457A1 · 2021 [cited by applicant]
GB 2179455A · 1987 [cited by applicant]
JP H01274498A · 1989 [cited by applicant]
JP H04206696A · 1992 [cited by applicant]
JP H04319334A · 1992 [cited by applicant]
JP H05317280A · 1993 [cited by applicant]
JP H06283888A · 1994 [cited by applicant]
JP H1183965A · 1999 [cited by applicant]
JP 2000254108A · 2000 [cited by applicant]
JP 2002028144A · 2002 [cited by applicant]
JP 2002355229A · 2002 [cited by applicant]
JP 2004041739A · 2004 [cited by applicant]
JP 2004237083A · 2004 [cited by applicant]
JP 2004337478A · 2004 [cited by applicant]
JP 2005003503A · 2005 [cited by applicant]
JP 2005080951A · 2005 [cited by applicant]
JP 2005217341A · 2005 [cited by applicant]
JP 2007117669A · 2007 [cited by applicant]
JP 2008307141A · 2008 [cited by applicant]
JP 2012110489A · 2012 [cited by applicant]
JP 2014525787A · 2014 [cited by applicant]
JP 2015091359A · 2015 [cited by applicant]
JP 2016012501A · 2016 [cited by applicant]
JP 2016101264A · 2016 [cited by applicant]
JP 2016530019A · 2016 [cited by applicant]
KR 20180046432A · 2018 [cited by applicant]
WO WO1998049938A1 · 1998 [cited by applicant]
WO WO2002017769A2 · 2002 [cited by applicant]
WO WO2005002313A2 · 2005 [cited by applicant]
WO WO2008005513A2 · 2008 [cited by applicant]
WO WO2011116229A2 · 2011 [cited by applicant]
WO WO2013011515A1 · 2013 [cited by applicant]
WO WO2014011940A2 · 2014 [cited by applicant]
WO WO2014152110A1 · 2014 [cited by applicant]
WO WO2015033244A1 · 2015 [cited by applicant]
WO WO2015085011A1 · 2015 [cited by applicant]
WO WO2015129756A1 · 2015 [cited by applicant]
WO WO2016205731A1 · 2016 [cited by applicant]
WO WO2018069287A1 · 2018 [cited by applicant]
WO WO2018217655A1 · 2018 [cited by applicant]
WO WO2019032857A1 · 2019 [cited by applicant]
WO WO2020106284A1 · 2020 [cited by applicant]
WO WO2020163593A1 · 2020 [cited by applicant]
WO WO20210242868A1 · 2021 [cited by applicant]
WO WO2022178314A1 · 2022 [cited by applicant]
WO WO2023168392A2 · 2023 [cited by applicant]
Kangwanariyakul, Y., Nantasenamat, C., Tantimongcolwat, T., & Naenna, T. (2010). Data mining of magnetocardiograms for prediction of ischemic heart disease. EXCLI journal, 9, 82. (Year: 2010). [cited by examiner]
Tao, R., Zhang, S., Huang, X., Tao, M., Ma, J., Ma, S., . . . & Xie, X. (2018). Magnetocardiography-based ischemic heart disease detection and localization using machine learning methods. IEEE Transactions on Biomedical… [cited by examiner]
Zhang, X., Zou, Y., & Shi, W. (Aug. 2017). Dilated convolution neural network with LeakyReLU for environmental sound classification. In 2017 22nd international conference on digital signal processing (DSP) (pp. 1-5). IE… [cited by examiner]
Yu, F., & Koltun, V. (2016). Multi-scale context aggregation by dilated convolutions. arXiv preprint arXiv:1511.07122. (Year: 2016). [cited by examiner]
Huszar, F. (2016). Dilated convolutions and Kronecker factored convolutions. Retrieved from: www.inference.vs/dilated-convolutions-and-kronecker-factorisation/ (Year: 2016). [cited by examiner]
Algra, A., et al., Heart rate variability from 24-hour electrocardiogramand the 2-year risk for sudden death, Circulation, 88(1): 180-185 (1993). [cited by applicant]
Amsterdam, E.A., et al., Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association, Circulation, 122(17): 1756-1776 (2010). [cited by applicant]
Arbab-Zadeh, A., Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm, Heart Int, 7(1): e2 (2012). [cited by applicant]
Ashokprabhu, N., et al., Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technology, Am Heart J Plus, 44: 100424, pp. 1-7 (2024). [cited by applicant]
Bousaa, M., et al., ECG signals classification using MFCC coefficients and ANN classifier, 2nd International Conference on Electrical and Information Technologies ICEIT, pp. 1-5 (2016). [cited by applicant]
Chen, J., et al., Age and sex dependent variations in the normal magnetocardiogram compared with changes associated with ischemia, Ann Biomed Eng, 32(8): 1088-1099 (2004). [cited by applicant]
CN201880048311.1 Chinese Office Action dated Mar. 8, 2022. [cited by applicant]
Desai, A.D., et al., Prognostic Significance of Quantitative QRS Duration, Am J Med, 119(7): 600-606 (2006). [cited by applicant]
EP Application No. 16812571.4 94(3) Communication dated Aug. 30, 2021. [cited by applicant]
EP Application No. 18940759.6 Extended European Search Report dated Jun. 3, 2022. [cited by applicant]
EP18805647.7 Extended European Search Report dated Dec. 17, 2020. [cited by applicant]
EP18844754.4 Extended European Search Report dated Mar. 12, 2021. [cited by applicant]
Fenici, R., et al., Clinical application of magnetocardiography, Expert Rev Mol Diagn, 5(3): 291-313 (2005). [cited by applicant]
Fenici, R., et al., Clinical validation of machine learning for automatic analysis of multichannel magnetocardiography, Proceedings of the Third International Conference on Functional Imaging and Modeling of the Heart (… [cited by applicant]
Haberkorn, W., et al., Pseudo current density maps of electrophysiological heart, nerve or brain function and their physical basis, Biomagn Res Technol, 4:5 (2006). [cited by applicant]
Hänninen, H., et al., Features of ST segment and T-wave in exercise-induced myocardial ischemia evaluated with multichannel magnetocardiography, Ann Med, 34(2): 120-129 (2002). [cited by applicant]
He, K., et al., A high-performance compact magnetic shield for optically pumped magnetometer-based magnetoencephalography, Rev Sci Instrum, 90(6): 064102, pp. 1-8 (2019). [cited by applicant]
Heron, M., et al., Deaths: Leading Causes for 2014, Natl Vital Stat Rep, 65(5): 1-96 (2016). [cited by applicant]
JP2019-564526 Japanese Office Action dated Jan. 25, 2023. [cited by applicant]
JP2019-564526 Japanese Office Action dated Mar. 22, 2022. [cited by applicant]
Jurkko, R., et al., Non-invasive detection of conduction pathways to left atrium using magnetocardiography: validation by intra-cardiac electroanatomic mapping, Eurospace, 11(2): 169-177 (2009). [cited by applicant]
Kataoka, H., et al., Changes in the amplitude of electrocardiogram QRS complexes during follow-up of heart failure patients, J Electrocardiol, 44(3):394.e1-9 (2011). [cited by applicant]
Kelshiker, M.A., et al., Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis, Eur Heart J, 43(16): 1582-1593 (2022). [cited by applicant]
Killman, R., et al., Localisation of myocardial ischaemia from the magnetocardiogram using current density reconstruction method: computer simulation study, Med Biol Eng Comput, 33(5): 643-651 (1995). [cited by applicant]
Kurl, S., et al., Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men, Circulation, 125(21): 2588-2594 (2012). [cited by applicant]
Liao, Y., et al., Denoising of Magnetocardiography Based on Improved Variational Mode Decomposition and Interval Thresholding Method, Symmetry, 10(7): 269 (2018). [cited by applicant]
Lyons, J., Mel Frequency Cepstral Coefficient (MFCC) tutorial, retrieved on Jun. 6, 2017 from <http://practicalcryptography.com/miscellaneous/machine-learning/guide-mel-frequency-cepstral-coefficients-mfccs/>. [cited by applicant]
Mace, S.E., et al., Accelerated magnetocardiography in the evaluation of patients with suspected cardiac ischemia: The Magneto trial, Am Heart J Plus, 40: 100372, pp. 1-7 (2024). [cited by applicant]
Malik, M., et al., Heart rate variability: Standards of measurement, physiological interpretation, and clinical use, Eur Heart J, 17(3): 354-381 (1996). [cited by applicant]
Moseley, M.G., et al., Emergency department observation units and the older patient, Clin Geriatr Med, 29(1): 71-89 (2013). [cited by applicant]
Oehler, A., et al., QRS-T angle: a review, Ann Noninvasive Electrocardiol, 19(6): 534-542 (2014). [cited by applicant]
Park, J-W., et al., Magnetocardiography predicts coronary artery disease in patients with acute chest pain, Ann Noninvasive Electrocardiol, 10(3): 312-323 (2005). [cited by applicant]
PCT/US2016/038209 International Preliminary Report on Patentability mailed Dec. 28, 2017. [cited by applicant]
PCT/US2016/038209 International Search Report and Written Opinion mailed Sep. 14, 2016. [cited by applicant]
PCT/US2018/033719 International Preliminary Report on Patentability mailed Nov. 26, 2019. [cited by applicant]
PCT/US2018/033719 International Search Report and Written Opinion mailed Aug. 27, 2018. [cited by applicant]
PCT/US2018/046055 International Preliminary Report on Patentability mailed Feb. 11, 2020. [cited by applicant]
PCT/US2018/046055 International Search Report and Written Opinion mailed Oct. 17, 2018. [cited by applicant]
PCT/US2018/062113 International Search Report and Written Opinion mailed Jan. 31, 2019. [cited by applicant]
PCT/US2020/017010 International Preliminary Report on Patentability dated Aug. 10, 2021. [cited by applicant]
PCT/US2020/017010 International Search Report and Written Opinion mailed May 4, 2020. [cited by applicant]
PCT/US2021/034269 International Preliminary Report on Patentability mailed Nov. 17, 2022. [cited by applicant]
PCT/US2021/034269 International Search Report and Written Opinion mailed Sep. 8, 2021. [cited by applicant]
PCT/US2022/017085 International Preliminary Report on Patentability dated Aug. 22, 2023. [cited by applicant]
PCT/US2022/017085 International Search Report and Written Opinion mailed Mar. 14, 2022. [cited by applicant]
PCT/US2023/063666 International Search Report and Written Opinion mailed Sep. 5, 2023. [cited by applicant]
Peguero, J.G., et al., Electrocardiogrameria for the Diagnosis of Left Ventricular Hypertrophy, J Am Coll Cardiol, 69(13): 1694-1703 (2017). [cited by applicant]
Ramesh, R., et al., Magnetocardiography for identification of coronary ischemia in patients with chest pain and normal resting 12-lead electrocardiogram, Ann Noninvasive Electrocadiol, 25(3): e12715 (2020). [cited by applicant]
Reinhardt, S.W., et al., Noninvasive Cardiac Testing vs Clinical Evaluation Alone in Acute Chest Pain: A Secondary Analysis of the ROMICAT-II Randomized Clinical Trial, JAMA Intern Med, 178(2): 212-219 (2018). [cited by applicant]
Sara, J.D., et al., Electrocardiogramonary microvascular dysfunction in patients with non-obstructive coronary artery disease: Utility of a novel T wave analysis program, Int J Cardiol, 203: 601-606 (2016). [cited by applicant]
Sasada, I., et al., Effective shielding for low-level magnetic fields, J Appl Phys, 64(10): 5696-5698 (1988). [cited by applicant]
Sugrue, A., et al., Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy, Open Heart, 4(1): e000561 (2017). [cited by applicant]
Taha, Y.K., et al., Electrocardiogramadictors of major adverse cardiac events in women with ischemia and number obstructive coronary artery disease (INOCA), Eur Heart J, 41(Suppl 2): 3188 (2020). [cited by applicant]
Tantimongcolwat, T., et al., Identification of ischemic heart disease via machine learning analysis on magnetocardiograms, Comput Biol Med, 38(7): 817-825 (2008). [cited by applicant]
Tao, R., et al., Magnetocardiography-Based Ischemic Heart Disease Detection and Localization Using Machine Learning Methods, IEEE Trans Biomed Eng, 66(6): 1658-1667 (2019). [cited by applicant]
Tsukada, K., et al., An iso-integral mapping technique using magnetocardiogram, and its possible use for diagnosis of ischemic heart disease, Int J Card Imaging, 16(1): 55-66 (2000). [cited by applicant]
U.S. Appl. No. 16/197,264 Office Action mailed Feb. 5, 2019. [cited by applicant]
U.S. Appl. No. 16/197,264 Office Action mailed Jul. 31, 2019. [cited by applicant]
U.S. Appl. No. 16/775,630 Office Action mailed Apr. 23, 2020. [cited by applicant]
U.S. Appl. No. 17/129,585 Office Action mailed Apr. 16, 2021. [cited by applicant]
U.S. Appl. No. 17/129,585 Office Action mailed Aug. 24, 2021. [cited by applicant]
U.S. Appl. No. 17/830,879 Office Action mailed Mar. 31, 2023. [cited by applicant]
U.S. Appl. No. 14/941,455 Notice of Allowance mailed Jul. 7, 2016. [cited by applicant]
U.S. Appl. No. 14/941,455 Office Action mailed Apr. 4, 2016. [cited by applicant]
U.S. Appl. No. 14/941,455 Office Action mailed Feb. 17, 2016. [cited by applicant]
U.S. Appl. No. 15/220,982 Notice of Allowance mailed May 9, 2017. [cited by applicant]
U.S. Appl. No. 15/220,982 Office Action mailed Dec. 27, 2016. [cited by applicant]
U.S. Appl. No. 15/601,417 Office Action dated Sep. 27, 2017. [cited by applicant]
U.S. Appl. No. 15/607,053 Notice of Allowance mailed May 15, 2018. [cited by applicant]
U.S. Appl. No. 15/607,053 Office Action mailed Dec. 22, 2017. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated Feb. 5, 2021. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated May 11, 2020. [cited by applicant]
U.S. Appl. No. 15/673,067 Office Action dated Oct. 13, 2020. [cited by applicant]
U.S. Appl. No. 15/985,512 Notice of Allowance dated Jul. 27, 2022. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Feb. 11, 2022. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Feb. 12, 2021. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Sep. 21, 2021. [cited by applicant]
U.S. Appl. No. 15/985,512 Office Action dated Sep. 25, 2020. [cited by applicant]
U.S. Appl. No. 16/104,528 Office Action mailed Feb. 26, 2020. [cited by applicant]
U.S. Appl. No. 16/104,528 Office Action mailed Nov. 7, 2019. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Aug. 20, 2020. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Jan. 9, 2020. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated Jul. 1, 2019. [cited by applicant]
U.S. Appl. No. 16/271,705 Office Action dated May 1, 2020. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Feb. 28, 2024. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Jul. 18, 2022. [cited by applicant]
U.S. Appl. No. 16/636,860 Office Action dated Nov. 9, 2023. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Jun. 3, 2021. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Mar. 29, 2022. [cited by applicant]
U.S. Appl. No. 17/181,095 Office Action dated Sep. 29, 2021. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action dated Dec. 7, 2022. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action dated Oct. 6, 2023. [cited by applicant]
U.S. Appl. No. 17/403,029 Office Action mailed Jan. 29, 2024. [cited by applicant]
U.S. Appl. No. 17/972,889 Office Action mailed Feb. 1, 2024. [cited by applicant]
Van Leeuwen, P., et al., Changes in dipolar structure of cardiac magnetic field maps after ST elevation myocardial infarction, Ann Noninvasive Electrocardiol, 16(4): 379-387 (2011). [cited by applicant]
Voulgari, C., et al., Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives, Curr Cardiol Rev, 5(4): 251-262 (2009). [cited by applicant]
Watanabe, S., et al., Magnetocardiography in Early Detection of Electromagnetic Abnormality in Ischemic Heart Disease, J Arrhythmia, 24(1): 4-17 (2008). [cited by applicant]
Zhang, Y., et al., Electrocardiogramterval and mortality: a meta-analysis, Epidemiology, 22(5): 660-670 (2011). [cited by applicant]